Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevention of Myopia with Low-Dose Atropine
NCT00541177Phase 4Unknown
- Sponsor
- Min-Sheng General Hospital
- Start
- Apr 2007
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of atropine in myopia (2 arms), sponsored by Min-Sheng General Hospital. Primary endpoints: Cycloplegic Refraction at 1 year and Visual Acuity at 1 year. Status: unknown.
02
Drugs
atropine
03
Conditions
myopia
Beyond the preview
Go deeper on NCT00541177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00541177.